Hrzenjak T M, Popović M, Tiska-Rudman L
Faculty of Veterinary Medicine, Department of Biology, Zagreb, Croatia.
Pathol Oncol Res. 1998;4(3):206-11. doi: 10.1007/BF02905250.
u-PA is secreted by the most malignant tumors. As a response to u-PA synthesis surrounding cells synthetize inhibitors of plasminogen activators for tissue protection. Plasminogen activators were found also in earthworm tissue. From the tissue homogenate of earthworm Eisenia foetida the glycolipoprotein mixture named G-90 was isolated. It contains two serine proteases (P I, P II) with fibrinolytic and anticoagulative activities. The fibrinolytic activity of G-90, P I and P II was tested in an in vitro euglobulinic test applied to fibrin clot from blood plasma of patients suffered from malignant tumors. G-90 and above-mentioned proteases applied in this study showed euglobulinic time proportionally with the concentrations of added substances. The influence of G-90 on the fibrinolysis rate does not depend only on its concentration, but depends too on histological type of tissue (organ) where the malignant tumors are located. Enzyme P I and P II do not show this activity.
尿激酶型纤溶酶原激活剂(u-PA)由大多数恶性肿瘤分泌。作为对u-PA合成的反应,周围细胞合成纤溶酶原激活剂抑制剂以保护组织。在蚯蚓组织中也发现了纤溶酶原激活剂。从蚯蚓赤子爱胜蚓的组织匀浆中分离出名为G-90的糖脂蛋白混合物。它含有两种具有纤溶和抗凝活性的丝氨酸蛋白酶(P I、P II)。在对患有恶性肿瘤患者血浆纤维蛋白凝块进行的体外优球蛋白试验中测试了G-90、P I和P II的纤溶活性。本研究中应用的G-90和上述蛋白酶显示优球蛋白时间与添加物质的浓度成比例。G-90对纤溶速率的影响不仅取决于其浓度,还取决于恶性肿瘤所在组织(器官)的组织学类型。酶P I和P II不显示这种活性。